FKI Fki

    RNS Number : 1716X
  Melrose PLC
  20 June 2008
   

    The following announcement is an advertisement and not a prospectus and investors should not subscribe for any Melrose PLC shares except
on the basis of information in the prospectus published by Melrose PLC on 1 May 2008.
    Not for release, publication or distribution, in whole or in part, in or into any jurisdiction where to do so would constitute a
violation of the relevant laws of that jurisdiction.

    20 June 2008
    Melrose PLC ("Melrose")
    Recommended Acquisition of FKI plc ("FKI")
    Regulatory Update

    Melrose announces that it has now received all regulatory clearances applied for in relation to the implementation of the Acquisition of
FKI.
    The Placing and the Open Offer remain conditional upon the Scheme becoming effective and upon Admission. The Scheme remains conditional,
inter alia, upon approval by the Court.

    EXPECTED TIMETABLE OF PRINCIPAL EVENTS
 First Court hearing to sanction the Scheme                   27 June 2008
 Second Court hearing to confirm the Capital                  30 June 2008
 Reduction
 Effective Date of the Scheme                               1 July 2008(1)
 Admission to trading and commencement of              8.00 a.m. on 1 July
 dealings on the London Stock Exchange of New                      2008(1)
 Melrose Shares
    (1) These dates are indicative only and will depend, among other things, on the date upon which the Court sanctions the Scheme and
confirms the Capital Reduction.
    This announcement should be read in conjunction with the full text of the Prospectus and the Circular published by Melrose on 1 May 2008
in relation to the Acquisition (together the "Documents"). Copies of the Documents are available for inspection at the UK Listing
Authority's Document Viewing Facility, which is situated at: The Financial Services Authority, 25 The North Colonnade, Canary Wharf, London
E14 5HS. In addition, copies of the Documents are available for inspection during normal business hours on Monday to Friday of each week
(public holidays excepted) at Melrose PLC, Precision House, Arden Road, Alcester, Warwickshire B49 6HN and at Clifford Chance LLP, 10 Upper
Bank Street, London E14 5JJ up to and including the date of Admission and have also been published at www.melroseplc.net.
    Capitalised terms used, but not defined, in this announcement have the same meanings as given to them in the Documents.
    Enquiries:
    JPMorgan Cazenove (joint financial advisor and joint corporate broker to Melrose)
    Mark Preston                +44 (0) 20 7588 2828
    Laurence Hollingworth   +44 (0) 20 7588 2828
    Dresdner Kleinwort (joint financial advisor to Melrose)
    David Smith                   +44 (0) 20 7623 8000
    Investec (joint corporate broker to Melrose)
    Keith Anderson              +44 (0) 20 7597 5970
    M:Communications (PR advisor to Melrose)
    James Hill                      +44 (0) 20 7153 1559
    Nick Miles                     +44 (0) 20 7153 1535
    This announcement is not for publication or distribution, directly or indirectly, in or into the United States. This announcement is for
information only and does not constitute an offer or invitation to acquire or dispose of the New Melrose Shares or the Consideration Shares
in the United States. The New Melrose Shares and the Consideration Shares have not been and will not be registered under the United States
Securities Act of 1933, as amended (the "US Securities Act") or with any securities regulatory authority of any state or other jurisdiction
of the United States (as such term is defined in Regulation S under the US Securities Act), and accordingly, may not be offered or sold in
the United States except pursuant to an exemption from, or in a transaction not subject to, registration under the US Securities Act. There
will be no public offer of the New Melrose Shares or the Consideration Shares in the United States. It is expected that the Consideration
Shares will be issued in reliance upon the exemption from the registration requirements of the US Securities Act provided by Section 3(a)(10) thereof. The New Melrose Shares are being
offered and sold outside the United States in accordance with Regulation S under the US Securities Act.
    JPMorgan Cazenove is acting for Melrose and no one else in connection with the Acquisition, the Placing and the Open Offer and will not
be responsible to anyone other than Melrose for providing the protections afforded to clients of JPMorgan Cazenove nor for giving advice in
relation to the Acquisition, the Placing and the Open Offer or any matter or arrangement referred to in the following announcement.
    Dresdner Kleinwort is acting for Melrose and no one else in connection with the Acquisition and will not be responsible to anyone other
than Melrose for providing the protections afforded to clients of Dresdner Kleinwort nor for giving advice in relation to the Acquisition or
any matter or arrangement referred to in the following announcement.
    Investec is acting for Melrose and no one else in connection with the Placing and the Open Offer and will not be responsible to anyone
other than Melrose for providing the protections afforded to clients of Investec nor for giving advice in relation to the Placing and the
Open Offer or any matter or arrangement referred to in the following announcement.
    The release, publication or distribution of the following announcement in jurisdictions other than the United Kingdom may be restricted
by law and, therefore, any persons who are subject to the laws of any jurisdiction other than the United Kingdom should inform themselves
about, and observe, any applicable requirements.



This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
ACQPUUMUQUPRUBU

FKI Plc (LSE:FKI)
Historical Stock Chart
From Jun 2024 to Jul 2024

FKI Plc (LSE:FKI)
Historical Stock Chart
From Jul 2023 to Jul 2024